The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

The Brazil Veterinary Medicine Market, valued at USD 2.65 Billion in 2024, is projected to reach USD 4.15 Billion by 2030, ...

Hyderabad: Aurobindo Pharma has announced that Curateq Biologics Private Limited, a wholly owned subsidiary of the Company, ...

The strategic move is aimed at integrating automated, high-throughput gene synthesis into Regeneron's in-house laboratories.

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

The Hyderabad-based BSE smallcap company's revenue from operations surged by 23 per cent to ₹128.2 crore, compared to ₹104.1 ...

The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.

Some countries and regions in Asia recently saw an increase in the number of COVID-19 cases. According to Nikkei Asia, ...